IL91398A - Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane - Google Patents

Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane

Info

Publication number
IL91398A
IL91398A IL9139889A IL9139889A IL91398A IL 91398 A IL91398 A IL 91398A IL 9139889 A IL9139889 A IL 9139889A IL 9139889 A IL9139889 A IL 9139889A IL 91398 A IL91398 A IL 91398A
Authority
IL
Israel
Prior art keywords
capsule
weight
membrane
tablet
asymmetric
Prior art date
Application number
IL9139889A
Other languages
English (en)
Other versions
IL91398A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL91398A0 publication Critical patent/IL91398A0/xx
Publication of IL91398A publication Critical patent/IL91398A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Executing Machine-Instructions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
IL9139889A 1988-08-30 1989-08-23 Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane IL91398A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (2)

Publication Number Publication Date
IL91398A0 IL91398A0 (en) 1990-04-29
IL91398A true IL91398A (en) 1994-05-30

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9139889A IL91398A (en) 1988-08-30 1989-08-23 Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane

Country Status (26)

Country Link
EP (1) EP0357369B1 (pl)
JP (1) JPH07112971B2 (pl)
KR (1) KR920008701B1 (pl)
CN (2) CN1058387C (pl)
AT (1) ATE89162T1 (pl)
AU (1) AU615104B2 (pl)
CA (1) CA1338552C (pl)
CZ (1) CZ277763B6 (pl)
DD (1) DD289466A5 (pl)
DE (1) DE68906488T2 (pl)
DK (1) DK175178B1 (pl)
EG (1) EG19189A (pl)
ES (1) ES2041006T3 (pl)
FI (1) FI102515B1 (pl)
HU (1) HU222245B1 (pl)
IE (1) IE62859B1 (pl)
IL (1) IL91398A (pl)
MX (1) MX173942B (pl)
MY (1) MY104183A (pl)
NO (1) NO179232C (pl)
NZ (1) NZ230470A (pl)
PL (1) PL163079B1 (pl)
PT (1) PT91560B (pl)
RU (2) RU1837873C (pl)
YU (1) YU47422B (pl)
ZA (1) ZA896586B (pl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
JPH0794379B2 (ja) * 1990-08-07 1995-10-11 ファイザー・インコーポレーテッド 放出製剤における界面重合膜の使用方法
WO1992005775A1 (en) * 1990-09-28 1992-04-16 Pfizer Inc. Dispensing device containing a hydrophobic medium
JPH0733645A (ja) * 1992-05-28 1995-02-03 Elan Corp Plc 錠剤製剤
TW235239B (pl) * 1992-11-20 1994-12-01 Pfizer
CA2150019C (en) * 1992-11-30 1999-01-05 Scott M. Herbig Supported liquid membrane delivery devices
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
EP0758244B2 (en) * 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
WO1999001121A1 (en) * 1997-07-01 1999-01-14 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
UA63953C2 (uk) * 1997-07-01 2004-02-16 Пфайзер Продактс Інк. Дозована форма уповільненого вивільнення, що містить сертралін, (варіанти) та спосіб лікування (варіанти)
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
HK1040910B (en) * 1998-11-12 2009-06-26 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and metformin
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
RU2153930C1 (ru) * 1999-02-02 2000-08-10 ООО Научно-исследовательская фирма "Ультрасан" Сорбционная система с регулируемой десорбцией
AU4709000A (en) * 1999-05-17 2000-12-05 Dow Chemical Company, The Process for making cellulose ether capsules with organic acids
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
WO2003084511A1 (en) 2002-04-04 2003-10-16 Pfizer Products Inc. Palatable chewable tablet
US20040043067A1 (en) * 2002-06-19 2004-03-04 Salamone Joseph C. Fluorosiloxane matrix controlled diffusion drug delivery systems
AU2003260336C1 (en) * 2002-07-29 2008-05-29 Glaxo Group Limited Sustained release formulations comprising lamotrigine
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2009500339A (ja) * 2005-06-29 2009-01-08 アルザ・コーポレーシヨン 浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
CN101583620B (zh) 2005-11-28 2016-08-17 马里纳斯医药公司 加奈索酮组合物及其制备和使用方法
KR20090007568A (ko) * 2006-04-24 2009-01-19 화이자 프로덕츠 인코포레이티드 약물 전달 장치용 비대칭 막
EP2248541B1 (de) * 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
AU2010325746B2 (en) 2009-12-02 2016-02-25 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
WO2021094953A1 (en) 2019-11-14 2021-05-20 Pfizer Inc. 1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
AU2021217209A1 (en) 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
CN117752838A (zh) * 2023-12-14 2024-03-26 上海应用技术大学 一种摩擦释香微胶囊及方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (pl) * 1960-11-29
DE3167521D1 (en) * 1981-01-22 1985-01-17 Capsugel Ag A process for producing a pharmaceutical capsule having enteric properties
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
DE10075031I2 (de) * 1984-08-17 2004-07-01 Wellcome Found Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
DD289466A5 (de) 1991-05-02
PT91560B (pt) 1995-05-04
YU165789A (en) 1992-05-28
ZA896586B (en) 1991-04-24
EP0357369A2 (en) 1990-03-07
NO893450D0 (no) 1989-08-29
MX173942B (es) 1994-04-11
JPH07112971B2 (ja) 1995-12-06
FI894046L (fi) 1990-03-01
RU1837873C (ru) 1993-08-30
ATE89162T1 (de) 1993-05-15
IE62859B1 (en) 1995-03-08
DK175178B1 (da) 2004-06-28
KR900002821A (ko) 1990-03-23
JPH02174713A (ja) 1990-07-06
KR920008701B1 (ko) 1992-10-08
DK424489A (da) 1990-03-01
CN1058387C (zh) 2000-11-15
RU2093147C1 (ru) 1997-10-20
ES2041006T3 (es) 1993-11-01
NO179232B (no) 1996-05-28
CZ277763B6 (en) 1993-04-14
FI102515B (fi) 1998-12-31
DE68906488T2 (de) 1993-09-09
CN1125573A (zh) 1996-07-03
MY104183A (en) 1994-02-28
YU47422B (sh) 1995-03-27
DE68906488D1 (de) 1993-06-17
AU615104B2 (en) 1991-09-19
NO893450L (no) 1990-03-01
EP0357369A3 (en) 1991-10-02
EP0357369B1 (en) 1993-05-12
AU4089189A (en) 1990-05-31
NO179232C (no) 1996-09-04
FI102515B1 (fi) 1998-12-31
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
PL163079B1 (pl) 1994-02-28
HU222245B1 (hu) 2003-05-28
CN1042072A (zh) 1990-05-16
NZ230470A (en) 1991-06-25
IE892771L (en) 1990-02-28
PT91560A (pt) 1990-03-30
IL91398A0 (en) 1990-04-29
CA1338552C (en) 1996-08-27
FI894046A0 (fi) 1989-08-29
HUT74086A (en) 1996-11-28
EG19189A (en) 1994-11-30

Similar Documents

Publication Publication Date Title
US5612059A (en) Use of asymmetric membranes in delivery devices
EP0357369B1 (en) The use of asymetric membranes in delivery devices
US5178868A (en) Dosage form
US5876752A (en) Use of interfacially-polymerized membranes in delivery devices
CA2148837C (en) Delivery device having encapsulated excipients
IE61223B1 (en) Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties
EP0365947B1 (en) Novel dosage form
KR100527335B1 (ko) 서방형 약물 전달 기구
JP2007520421A (ja) 経口投与用放出制御型薬物送達システム
MXPA05000206A (es) Forma de dosificiacion oral que comprende una formulacion liquida de agente activo y liberacion controlada de la misma mediante una composicion osmotica expansible.
FI102455B (fi) Menetelmä oraalisen farmaseuttisen moniyksikköformulaation valmistamis eksi
HK1082418A (en) Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees